White House says popular weight-loss drug Ozempic subject to Medicare talks
Read more at MarketWatch
-
Ozempic among drugs targeted in upcoming Medicare price negotiations
Investors fret Novo Nordisk’s blockbuster treatments and other medicines could incur price cutsFinancial Times - 3h -
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.CNBC - 3h -
Medicare announces weight-loss drugs, including Ozempic, will be up for price negotiations
The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, which includes Ozempic.NBC News - 5h -
Medicare to Negotiate Lower Prices for Weight-Loss Drugs
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.The New York Times - 6h -
Ozempic, Wegovy on list for Medicare drug price negotiations
The hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.CBS News - 5h -
CMS to seek Medicare negotiations on Ozempic price
The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare negotiation. CMS listed Ozempic, Rybelsus and Wegovy — all forms of semaglutide ...The Hill - 6h -
Medicare's new $2,000 cap on out-of-pocket drug costs could save patients thousands, AARP says
The AARP report suggests the spending cap could be huge for Medicare enrollees who take costly drugs for cancer, rheumatoid arthritis, and other conditions.CNBC - 1d -
Melania Trump Says She Plans to Be at White House Full Time
Mrs. Trump did not immediately move in to the White House when her husband was inaugurated in 2017, but she said the second stay was going to be more routine. “I already packed,” she told Fox News.The New York Times - 4d -
Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face an uncertain future in the incoming Trump administration.NBC News - Jan. 9
More from MarketWatch
-
The Biden economy: Just how good was it? Here are the highs and lows for the 46th president.
Presidents get too much credit or too much blame for the economy, it’s often said, but the public never fails to render its own judgment. They gave Joe Biden and Kamala Harris a failing grade and ...MarketWatch - 29m -
Capital One lawsuit reveals how bank customers can get smart and get their money’s worth
A new lawsuit alleging that Capital One cheated savers out of larger yields is a wake-up call for people who want to wise up and get the most out of their deposits, experts say.MarketWatch - 41m -
Tesla’s stock is surging ahead of Trump’s inauguration. What matters after that.
Tesla’s stock surges ahead of Inauguration Day, as investors bet on CEO Elon Musk’s ability to influence Federal rule making.MarketWatch - 43m -
Bond funds are offering a ‘double whammy’ for investors
Many of these funds are trading at deep discounts and may have tempting distribution yieldsMarketWatch - 47m -
With XRP near highs ahead of Trump inauguration, can bitcoin crack a new record?
Major cryptocurrencies rallied on Friday, with bitcoin back on track toward its record high days ahead of the second inauguration of crypto-friendly President-elect Donald Trump.MarketWatch - 57m
More in Business
-
Vanguard to pay more than $100 million by SEC over violations involving target date retirement funds
The payment stems from a 2020 change by Vanguard that led to redemptions in one class of target date funds.CNBC - 5m -
RFK Jr. Sought to Stop Covid Vaccinations 6 Months After Rollout
Robert F. Kennedy Jr. petitioned the F.D.A. to revoke authorization of the shots at a time when they were in high demand and considered life-saving.The New York Times - 10m -
Bluesky’s Bot Problem Is a Byproduct of Its Success. Users Are Not Amused.
There’s a reported uptick in bots spamming the hot new social platform, throwing a wrench in its plans to compete with X and Threads.Inc. - 12m -
Vanguard to Pay $106 Million in Restitution to Retirement Fund Investors
An investigation by the S.E.C. and several states found that the company had failed to notify investors of changes in the terms of some funds, leading to higher capital gains taxes.The New York Times - 14m -
Sam Altman posts letter from senators concerned about OpenAI efforts to 'cozy up' to Trump
On his X account, Sam Altman posted a letter signed by Democratic senators concerned about the ways tech companies appear to be bending to Trump's wishes.CNBC - 14m